.svg){kind=small}
Sep-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of California, My Blue Dove has shown varied performance across different product categories. Within the Tincture & Sublingual category, the brand has experienced a decline in ranking over the months from June to September 2024, moving from 10th to 18th place. This decrease in rank is notable, especially considering the initial strong position in June. Despite the drop in ranking, the sales figures suggest some level of consistency in the latter months, indicating a potential stabilization in this category. In the Topical category, My Blue Dove was ranked 14th in June, but did not maintain a top 30 position in the following months. This absence in the rankings post-June could be seen as a challenge for the brand in maintaining visibility and market share in this specific category.
While the Tincture & Sublingual category has shown a downward trajectory in California, the brand's performance in the Topical category raises questions about its strategic focus and market penetration. The absence from the top 30 rankings beyond June suggests that competitors may be gaining ground or that consumer preferences are shifting. This data highlights the importance for My Blue Dove to reassess its market strategies and possibly diversify its offerings or strengthen its marketing efforts to regain traction. Understanding these movements can provide insight into broader market trends and the competitive landscape within the cannabis industry, offering valuable information for stakeholders and industry analysts alike.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, My Blue Dove has experienced a notable decline in its ranking, dropping from 10th place in June 2024 to 18th place by September 2024. This downward trend in rank is mirrored by a significant decrease in sales, suggesting a potential loss of market share. Meanwhile, competitors like Chemistry have maintained relatively stable positions, fluctuating between 10th and 13th place, indicating a more consistent performance. Dr. May has shown an upward trajectory, improving its rank from 19th in June to 16th in September, accompanied by an increase in sales, which could signal a growing preference among consumers. Additionally, brands like High Power and Mama Sue have entered the top 20 rankings intermittently, suggesting emerging competition that could further impact My Blue Dove's market position if current trends continue.
Notable Products
In September 2024, My Blue Dove's top-performing product was the Indica Tincture (1000mg THC, 30ml) in the Tincture & Sublingual category, maintaining its first-place rank with sales of 743 units. The High THC Full Spectrum Oil (1g) from the Concentrates category rose to the second position, showing a consistent upward trend from fifth place in June. The Sativa Tincture (1000mg THC, 30ml) dropped to third place, despite being the leader in August. The CBD MCT Tincture (500mg CBD, 30ml, 1oz) remained steady in fourth place, reflecting consistent demand. Lastly, the Hybrid Tincture (1000mg THC, 30ml) held its fifth-place rank, having re-entered the top five in August after an absence in July.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
